Effects of Acute and Chronic Graft-versus-myelodysplastic Syndrome on Long-term Outcomes Following Allogeneic Hematopoietic Cell Transplantation.

导出原文传递

翻译打印收藏纠错

作者： Takaaki,Konuma ^[1] ; Ken,Ishiyama ^[2] ; Aiko,Igarashi ^[3] ; Naoyuki,Uchida ^[4] ; Yukiyasu,Ozawa ^[5] ; Takahiro,Fukuda ^[6] ; Yasunori,Ueda ^[7] ; Ken-Ichi,Matsuoka ^[8] ; Takehiko,Mori ^[9] ; Yuta,Katayama ^[10] ; Makoto,Onizuka ^[11] ; Tatsuo,Ichinohe ^[12] ; Yoshiko,Atsuta ; Adult Myelodysplastic Syndrome Working Group of the Japan Society for Hematopoietic Cell Transplantation

作者单位： Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. tkonuma@ims.u-tokyo.ac.jp. ^[1] Department of Hematology, Kanazawa University Hospital, Kanazawa, Japan. ^[2] Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan. ^[3] Department of Hematology, Toranomon Hospital, Tokyo, Japan. ^[4] Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan. ^[5] Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan. ^[6] Department of Hematology and Oncology, Kurashiki Central Hospital, Kurashiki, Japan. ^[7] Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan. ^[8] Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan. ^[9] Department of Hematology, Hiroshima Red Cross Hospital & Atomic-Bomb Survivors Hospital, Hiroshima, Japan. ^[10] Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan. ^[11] Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan. ^[12]